Justia Securities Law Opinion Summaries

Axsome Therapeutics, Inc., a biopharmaceutical company, developed AXS-07, an experimental migraine treatment. Beginning in late 2019, Axsome and its officers made public statements about AXS-07’s regulatory prospects and estimated filing dates for FDA approval, which plaintiffs allege were false and misleading because they omitted significant manufacturing and control deficiencies. Throughout 2020 and 2021, Axsome repeatedly delayed the expected FDA filing date for AXS-07. In April 2022, Axsome disclosed that the FDA had identified unresolved issues, causing its stock price to drop.After these disclosures, Axsome faced related litigation in the United States District Court for the Southern District of New York, including a securities class action and derivative lawsuits. The Securities Action was ultimately settled in 2026. The federal derivative suits were consolidated and stayed during the securities litigation. Meanwhile, in April and May 2025, plaintiffs in this Delaware action sent Section 220 books and records demands to Axsome, seeking company documents before filing suit. Axsome produced documents in September 2025, and the plaintiffs then filed this derivative lawsuit in the Court of Chancery of the State of Delaware.The Court of Chancery ruled that the plaintiffs’ claims were untimely under the doctrine of laches, applying Delaware’s three-year statute of limitations by analogy. The court held that the claims accrued by April 22, 2022, at the latest, and that neither the late and informally served Section 220 demands nor the existence of federal litigation tolled or excused the delay. The Court of Chancery concluded that the mere transmission of books and records demands did not suspend the limitations period, found no extraordinary circumstances to rebut the presumption of prejudice, and dismissed the complaint with prejudice as time-barred. View "In Re Axsome Therapeutics, Inc. Stockholder Derivative Litigation" on Justia Law

A company that had succeeded Bed Bath & Beyond after bankruptcy sued two investment entities, asserting that they owed the company profits made from short-term trading of its stock. Before the bankruptcy, Bed Bath & Beyond had sold derivative securities to the investment entities, giving them the right to acquire large amounts of its stock at a discount. However, the contracts for these derivatives included “blocker” provisions, which stated that the investment entities could not acquire more than 9.99% of the company’s stock at any time. The investment entities repeatedly exercised their rights under these contracts, buying and selling shares while maintaining their holdings below the 10% threshold.The United States District Court for the Southern District of New York reviewed the case after the successor company filed suit, arguing that the contractual blockers were illusory and that, in substance, the investment entities effectively had the right to acquire more than 10% of the stock, triggering liability under section 16(b) of the Securities Exchange Act of 1934. The district court dismissed the complaint, finding that the blockers were valid and shielded the defendants from section 16(b) liability.On appeal, the United States Court of Appeals for the Second Circuit reviewed the district court’s dismissal de novo. The court held that effective and enforceable contractual blockers, which cap an investor's beneficial ownership below 10% and are not sham provisions, prevent section 16(b) liability for short-swing profits. The court found no plausible allegations that the blockers were illusory or that the investment entities ever exceeded the 10% threshold. The Court of Appeals also rejected arguments that the parties’ contractual arrangements were part of a scheme to evade regulatory obligations. The judgment of the district court was affirmed in full. View "20230930-DK-BUTTERFLY-1,INC. v. HBC Invs. LLC" on Justia Law

An investor in a publicly traded biopharmaceutical company filed a proposed class action against the company and its CEO, alleging securities fraud. The plaintiff claimed that the company misled investors by suggesting that the FDA had approved their methodology for measuring a drug’s efficacy in clinical trials. The alleged misrepresentation was made in a press release that communicated the FDA’s input on the study’s endpoints, but, according to the plaintiff, failed to disclose that the FDA found the methodology unacceptable. When the company later announced it would not use the disputed methodology, the share price initially increased. A decline in the share price occurred over the next two days, during which the stock moved in line with the general market.The United States District Court for the Southern District of New York dismissed the complaint with prejudice, holding that the plaintiff failed to sufficiently plead loss causation, an essential element of a securities fraud claim. The court noted that the share price rose on the day of the corrective disclosure and only declined later, in tandem with the broader market. The district court also denied the plaintiff’s request to amend the complaint, reasoning that amendment would be futile.On appeal, the United States Court of Appeals for the Second Circuit reviewed the district court's dismissal de novo. The appellate court agreed that the plaintiff did not plausibly allege loss causation. It explained that when a stock price does not fall immediately after a corrective disclosure, and a later decline coincides with general market losses, a plaintiff must provide a plausible explanation linking the loss to the alleged fraud. Because the plaintiff failed to do so, the Second Circuit affirmed the district court’s judgment and denial of leave to amend. View "Huey v. Anavex Life Sciences Corporation" on Justia Law

A group of investors lost money after purchasing interests in a hedge fund operated by Constantine Antonas between 2015 and 2021. Antonas was not a registered investment adviser and did not qualify for an exemption from registration. He solicited investments using a Private Placement Memorandum (PPM) that identified a brokerage firm as the fund’s broker, which the investors claimed gave legitimacy to the scheme. After collecting approximately $25 million, Antonas lost nearly all the funds through speculative trades and died in 2021, leaving the investors without recourse against him.The investors filed suit in the Cuyahoga County Court of Common Pleas against the brokerage firm, alleging that it had participated in or aided Antonas's unlawful sale of securities in violation of Ohio law, specifically R.C. 1707.43(A). They argued that because the brokerage firm reviewed the PPM and performed routine account setup and compliance procedures before and after the fund’s account was opened, it should be liable for their losses. The trial court dismissed the amended complaint for failure to state a claim. However, the Eighth District Court of Appeals reversed, holding that the investors' allegations were sufficient to state a claim for relief under R.C. 1707.43(A).The Supreme Court of Ohio reviewed the case and held that R.C. 1707.43(A) does not impose liability on a brokerage firm for routine business activities performed after an unlawful sale of securities has occurred. The Court found no nexus between the brokerage firm's conduct and the solicitation, negotiation, or execution of the specific securities sales to the investors. As a result, the Supreme Court of Ohio reversed the appellate court’s decision and reinstated the trial court’s dismissal of the amended complaint. View "Bitounis v. Interactive Brokers, L.L.C." on Justia Law

The case concerns actions taken by the former CEO of a prominent cryptocurrency exchange and a related trading firm. The defendant, who exercised substantial control over both entities, was accused of misappropriating billions of dollars of customer funds. These funds, which customers believed would be safely held and used only for authorized transactions, were instead funneled to the trading firm and used for various unauthorized purposes, including investments, political contributions, and purchases of real estate. The collapse of cryptocurrency markets in 2022, followed by a rapid loss of customer confidence and mass withdrawals, ultimately led to the bankruptcy of both the exchange and the trading firm.After the bankruptcy, the defendant was indicted in the United States District Court for the Southern District of New York on several counts of fraud and conspiracy. The government’s case was supported by testimony from the defendant’s close associates, who described how the defendant orchestrated the transfer and misuse of customer funds, and by business records and communications. The defendant argued that he believed all customers would ultimately be repaid and that he acted in good faith. The jury found the defendant guilty on all counts, and the district court sentenced him to 25 years in prison, imposed a three-year term of supervised release, and ordered a forfeiture of approximately $11 billion.On appeal to the United States Court of Appeals for the Second Circuit, the defendant challenged the district court’s evidentiary rulings, jury instructions, discovery-related decisions, and the forfeiture order. The Second Circuit held that the district court did not err in its evidentiary rulings, instructions, or discovery decisions, and that the forfeiture was authorized and not constitutionally excessive. The judgment of the district court was affirmed. View "U.S. v. Bankman-Fried" on Justia Law

Several investment companies managing closed-end mutual funds, incorporated in Maryland, adopted resolutions under the Maryland Control Share Acquisition Act (MCSAA) to limit the voting rights of shareholders who accumulate a large percentage of shares, such as activist investors. Saba Capital, an activist investor, sought to acquire significant stakes in these funds to influence their management. Saba challenged the funds’ resolutions, alleging they violated the Investment Company Act’s (ICA) requirement that every share of stock have equal voting rights. Saba based its legal claim on Section 47(b) of the ICA, which addresses rescission of contracts that violate the Act.The United States District Court ruled in Saba’s favor, holding that Section 47(b) of the ICA creates an implied private right of action that allows private parties to sue for rescission of contracts allegedly violating the ICA. The District Court granted summary judgment to Saba on this basis. The United States Court of Appeals for the Second Circuit summarily affirmed the District Court’s decision.The Supreme Court of the United States reviewed the case to resolve a circuit split regarding whether Section 47(b) of the ICA impliedly authorizes private parties to sue for rescission. The Court held that Section 47(b) does not confer an implied private right of action. The Court reasoned that the provision directs courts on how to exercise remedial authority in cases already before them but does not create a right for private parties to initiate such suits. The statutory text and structure, including the explicit enforcement roles given to the Securities and Exchange Commission and the existence of other express private rights of action in the ICA, further supported this conclusion. The Supreme Court reversed the Second Circuit’s judgment and remanded the case for further proceedings. View "FS Credit Opportunities Corp. v. Saba Capital Master Fund, Ltd." on Justia Law

The defendant created a company called Icy Gulch Resources, LLC, and solicited investments from five individuals through subscription agreements and short-term loans—both considered securities under Maine law. She misrepresented Icy Gulch’s involvement in several ventures, including falsely claiming a stake in the Sudanese gum arabic market, and asserted that wealthy individuals were participating in the deals. Contrary to these representations, Icy Gulch held no such interests, and there was no plan for financial benefit for the investors. The defendant also comingled investor funds with personal assets and spent substantial amounts on personal expenses without disclosure or permission. The total invested by the five individuals was $786,000, with $936,000 invested across all her projects, none of which was returned or yielded any profit.In May 2019, the State charged the defendant in the Cumberland County Unified Criminal Docket with theft by deception and securities fraud. Before trial, the court ruled that evidence of a 2012 indictment for similar conduct could be used only if the defendant claimed ignorance about the misuse of investor funds. The defendant waived her right to a jury trial on the securities fraud charge, which was tried by the judge, while the theft charge went to a jury. The jury convicted her of theft by deception; the judge found her guilty of securities fraud. The court denied her post-trial motions and imposed concurrent sentences, with partial suspension.On appeal, the Maine Supreme Judicial Court reviewed the case. The Court held that sufficient evidence supported both convictions, as the record demonstrated deception, material misrepresentations, and misuse of funds. The Court found that arguments regarding hearsay were waived for lack of specific identification and that, regardless, the challenged evidence was properly admitted. It also held that the trial court did not abuse its discretion regarding the potential use of the prior indictment. The convictions and denial of post-trial motions were affirmed. View "State of Maine v. Flynn" on Justia Law

A robotics company, whose primary product is a well-known robot vacuum, agreed in August 2022 to be acquired by a major online retailer. Over the next eighteen months, the companies sought approval for the merger from regulatory authorities in the United States and Europe. In January 2024, facing significant regulatory obstacles, the parties abandoned the merger. Following this, shareholders of the robotics company, led by an investment fund, brought a securities fraud class action against the company’s CEO and CFO. They alleged that during the merger’s review period, company statements misrepresented or omitted material information regarding the likelihood of regulatory approval, particularly concerning the company’s expectation of approval and the acquirer’s cooperation with regulators.The United States District Court for the District of Massachusetts dismissed the amended complaint with prejudice. The court found that the plaintiffs failed to identify any actionable material misrepresentation or omission and did not adequately allege scienter (the intent or knowledge of wrongdoing). During the appeal, the robotics company entered Chapter 11 bankruptcy, resulting in its dismissal from the appeal, which continued as to the individual defendants.The United States Court of Appeals for the First Circuit reviewed the case. It agreed with the district court that the complaint failed to state a claim for most of the statements challenged by the plaintiffs, affirming dismissal as to those. However, the court found that the amended complaint plausibly alleged that an August 24, 2023, proxy statement expressed an opinion about expected regulatory approval while omitting important contrary information regarding European regulatory concerns and the acquirer’s refusal to cooperate. This omission, in the circumstances, was sufficient to state a claim as to that statement. The dismissal was reversed in part and affirmed in part, and the case was remanded for further proceedings. View "Premca Extra Income Fund LP v. Angle" on Justia Law

The appellant, an experienced foreign currency exchange (FX) trader, claimed he uncovered manipulation in the FX market after noticing a sharp drop in the values of several currencies relative to the Swiss franc in 2011. He believed this was due to collusion among market makers and shared his suspicions with various regulators, including the Commodity Futures Trading Commission (CFTC). His allegations focused on conduct by a retail trading platform, Oanda, and mentioned possible involvement by banks but did not name any specific institutions. Two years later, media reports surfaced about large banks rigging FX benchmark rates, prompting the CFTC to investigate and eventually reach settlements with several banks for manipulating benchmark rates.The CFTC initially investigated the appellant’s allegations against Oanda but found no evidence of wrongdoing and closed the case without action. The CFTC’s later enforcement actions against major banks were initiated after media coverage revealed benchmark-rate manipulation schemes, not because of the appellant’s information. After the settlements were announced, the appellant applied for a whistleblower award, arguing his tips had led to these enforcement actions. The CFTC’s Whistleblower Office and Claims Review Staff recommended denial, finding his tips were not the original source of the information leading to the enforcement actions. The appellant sought reconsideration and, after a delay, petitioned for mandamus relief in the United States Court of Appeals for the District of Columbia Circuit, which was rendered moot when the Commission issued final orders denying his application.The United States Court of Appeals for the District of Columbia Circuit reviewed the CFTC’s denial for arbitrariness or capriciousness. The court found that the appellant’s tips did not lead to or significantly contribute to the enforcement actions against the banks, nor was he the original or derivative source of the information used. The court affirmed the CFTC’s orders denying the whistleblower award. View "Kitchen v. Commodity Futures Trading Commission" on Justia Law

Ongkaruck Sripetch orchestrated several fraudulent schemes involving over 20 penny-stock companies. These schemes included classic “pump and dump” operations, where Sripetch and his associates would acquire shares, artificially inflate their value through promotion, and then sell at a profit. The Securities and Exchange Commission (SEC) discovered these activities and filed a civil enforcement action, charging Sripetch with six counts of securities fraud and one count of selling unregistered securities. Sripetch consented to judgment and agreed that the court could order disgorgement of ill-gotten gains.The United States District Court for the Southern District of California reviewed the SEC’s request for more than $4.1 million in disgorgement. Sripetch objected, arguing that the SEC had not demonstrated that investors suffered financial losses. The district court rejected this objection, finding that the SEC had made an adequate showing of pecuniary harm suffered by investors, but it did not decide whether such a showing was necessary. Sripetch appealed to the United States Court of Appeals for the Ninth Circuit, which held that a finding of pecuniary harm is not required for a disgorgement order, relying on traditional equitable principles and relevant Restatements. The court’s decision deepened a split among the circuits.The Supreme Court of the United States granted certiorari to resolve whether the SEC must prove that investors suffered financial losses to obtain disgorgement. The Court held that a showing of pecuniary loss is not required before the SEC may secure a disgorgement award. The main holding is that, under traditional equitable principles and the relevant statutes, disgorgement may be ordered based on the defendant’s wrongful gain, regardless of whether the victims suffered financial losses. The Court affirmed the judgment of the Ninth Circuit. View "Sripetch v. SEC" on Justia Law